1. Home
  2. Aromatase inhibitor
  Subject:

Aromatase inhibitor   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Breast cancer Hormone Estrogen receptor Enzyme inhibitor Progression-free survival Neu! Letrozole Tamoxifen Stomatitis Steroid sulfatase Aromatase inhibitor Chemotherapy Gene Metastasis Metabolism Protein Growth factor Apoptosis Western blot Messenger RNA Multivariate analysis Neutropenia Estrogen Estradiol Endocrine system Adjuvant therapy Mechanistic target of rapamycin Everolimus Ichthyosis
RELATED SUBJECTS:
The publications listed also have these subjects
Breast cancer  10 times
Hormone  7 times
Estrogen receptor  6 times
Enzyme inhibitor  5 times
Progression-free survival  4 times
Neu!  3 times
Tamoxifen  2 times
Stomatitis  2 times
Mechanistic target of rapamycin  2 times
Lymph node  2 times
Hypothalamus  2 times
Growth factor  2 times
Gene  2 times
Estrogen  2 times
Endocrine system  2 times
Biopsy  2 times
Topical medication  1 time
Testosterone  1 time
TNBC  1 time
Statistical hypothesis testing  1 time
Sirolimus  1 time
Sex steroid  1 time
Sentinel lymph node  1 time
Sarcoma  1 time
Radiation therapy  1 time
Protein  1 time
Prenatal development  1 time
Precision medicine  1 time
Placebo  1 time
Pituitary gland  1 time
Ovary  1 time
Obesity  1 time
Neutropenia  1 time
Neoplasm  1 time
Neoadjuvant therapy  1 time
Mouse  1 time
Monoclonal antibody  1 time
Microarray  1 time
Metastasis  1 time
Messenger RNA  1 time
Japan  1 time
Invasive carcinoma of no special type  1 time
Interquartile range  1 time
International law  1 time
Insulin-like growth factor 1 receptor  1 time
Insulin  1 time
Immunoprecipitation  1 time
Hysterectomy  1 time
Hypovolemia  1 time
Hyperprolactinaemia  1 time
Hyperglycemia  1 time
Histology  1 time
Genome-wide association study  1 time
Gene ontology  1 time
G1 phase  1 time
Everolimus  1 time
Estrone  1 time
Estradiol  1 time
Epigenetics  1 time
Eocene  1 time
Cyclin-dependent kinase 4  1 time
Cyclin-dependent kinase  1 time
Chromosome  1 time
Chemotherapy  1 time
Cell cycle  1 time
Carcinoma  1 time
Body mass index  1 time
Blood plasma  1 time
Artificial intelligence  1 time
Arthralgia  1 time
Aromatase  1 time
Anorexia nervosa  1 time
Androstenedione  1 time
Androgen  1 time
Allele  1 time
Agonist  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

2. Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer

3. Ribociclib: First Global Approval

4. A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer

5. Sex differences in microRNA-mRNA networks: examination of novel epigenetic programming mechanisms in the sexually dimorphic neonatal hypothalamus

6. Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats

7. A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

8. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report

9. Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population

10. SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

11. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study)

12. Primary ectopic breast cancer of the vulva, treated with local excision of the vulva and sentinel lymph node biopsy: a case report

13. Extended Endocrine Therapy: Is 5 Years Enough?


Questions?

Drop us a message.